The Optimal Radiation Dose in Localized Head and Neck Diffuse Large Cell Lymphoma |
Koom Woong Sub
(Department of Radiation Oncolgy, Yonsei University College of Medicine)
Suh Chang Ok (Department of Radiation Oncolgy, Yonsei University College of Medicine) Kim Yong Bae (Department of Radiation Oncolgy, Yonsei University College of Medicine) Shim Su Jung (Department of Radiation Oncolgy, Yonsei University College of Medicine) Pyo Hongryull (Department of Radiation Oncolgy, Yonsei University College of Medicine) Roh Jae Kyung (Yonsei Cancer Center, Yonsei University College of Medicine) Chung Hyun Cheol (Yonsei Cancer Center, Yonsei University College of Medicine) Kim Gwi Eon (Department of Radiation Oncolgy, Yonsei University College of Medicine) |
1 | FuIIer LM, Krasin MJ, VeIasquez WS, et aI. Significance of tumor size and radistion dose to local control in stage I-III diffuse Iarge cell lymphoma treated with CHOP-Bleo and radiation. Int J Radat Oncol Biol Phys 1995;31:3-11 DOI ScienceOn |
2 | Sweet DL, Kinzie J, Gaeke ME, Golomb HM, Ferguson DL, UItmann JE. Survival of patients with localized diffuse histiocytic lymphoma. Blood 1981;58:1218-1223 PUBMED |
3 | HaIIahan D, Farah R, Vokes E, et aI. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated radiotherapy alone. Int J Radiat Oncol Bil Phys 1989;17:767-771 DOI ScienceOn |
4 | MiIIer TP, Jones SE. Chemotherapy of localized histiocytic lymphoma. Lancet 1979;1:358-360 |
5 | Connors JM, KIimo P, Fairey RN, Voss N. Brief chemotherapy and involved field radiation therapy for Iimited-stage, histologically aggressive lymphoma. Ann Intern Med 1987;107:25-30 PUBMED |
6 | Longo DL, GIatstein E, Duffey PL, et aI. Treatment of Iocalized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol 1989;7:1295-1302 PUBMED |
7 | Kaminski MS, CoIeman CN, CoIby TV, et aI. Factors predicting survival in aduIts with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Intern Med 1986;104:747-756 PUBMED |
8 | Bonadonna G, Bajetta E, Lattuada A, et aI. CVP versus BACOP chemotherapy sequentially combined with irradiation in stage I-II diffuse non-Hodgkin's lymphomas. In : Jones SE, Salmon SE, eds. Adjuvant therapy of cancer IV. Orlando, Fla. : Grune & Stratton, 1984;661-668 |
9 | Franzen L, Funegard U, Ericson T, et aI. Parotid gland function during and following radiotherapy of malgncies in the head and neck, a consecutive study of saIivary flow and patient discomfort. Eur J Cancer 1992;28:457-462 DOI ScienceOn |
10 | CabaniIIas F, Bodey GP, Freireich EJ. Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types. Cancer 1980;46:2356-2359 DOI ScienceOn |
11 | Kosuda S, Satoh M, Yamamoto F, Uematsu M, Kusano S. Assessment of salivary gland dysfunction following chemoradiotherapy using quantitive saIivary gland scintigraphy. Int J Radiat Oncol Biol Phys 1999;45:379-384 PUBMED |
12 | MiIIer TP, Jones SE. Initial chemotherapy for clinically locaIized lymphomas of unfavorable histology. Blood 1983;62:413-418 |
13 | Landberg TG, Hakansson LG, MoIIer TR, et aI. CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas: preliminary results of a randomized study. Cancer 1979;44:831-838 DOI ScienceOn |
14 | Tsujii H. Quantitative dose-response anaIysis of salivary function following radiotherapy using sequential RI-sialo-graphy. Int J Radiat Oncol Biol Phys 1985;11:1603-1612 DOI PUBMED ScienceOn |
15 | GIick JH, Kim K, EarIe J. An ECOG randomized phase III trial of CHOP vs CHOP plus radiotherapy for intermediate grade early stage non-Hodgkin's Iymphoma (abst). Proc Am Soc Clin Oncol 1995;14:391 |
16 | Levitt SH, BIoomfieId CD, Frizzera G, Lee C. Curative radiotherapy for locaIized diffuse histiocytic lymphoma. Cancer Treat Rep 1980;64:175-177 PUBMED |
17 | Nathu RM, MendenhaII PN, AImasri NM, Lynch JM. Non-Hodgkin's lymphoma of the head and neck: a 30-year experience at the university of florida. Head and Neck 1999;21:247-254 DOI ScienceOn |
18 | Liu RP, FIeming TJ, Toth BB, et aI. SaIivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Oral Surg Oral Med Oral Pathol 1986;61:243-245 |
19 | Levitt SH, Lee C, BIoomfieId CD, Frizzera G. The role of radiation therapy in the treatment of early stage large cell lymphoma. Hematol Oncol 1985;3:33-37 DOI PUBMED |
20 | Dreizen S, Brown LR, DaIy TE, et aI. Prevention of xero-stomia-related dental caries in irradiated cancer patient. J Dent Res 1977;56:99-104 DOI PUBMED ScienceOn |
21 | MiIIer TP, DahIberg S, Cassady JR, et aI. Chemotherapy alona compared with chemotherapy plus radiotherapy for Iocalized intermediate- and high-grade non-Hodgkin's Iymphoma. N Engl J Med 1998;399:21-26 |
22 | Nissen NI, ErsboII J, Hansen HS, et aI. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer 1983;52:1-7 DOI ScienceOn |
23 | Kamath SS, Marcus RB, Lynch JW, MendenhaII NP. The impact of radiotherapy dose and other treatment-related and clinical factors on in-fild control in stage I and II non-Hodgkin's Iymphoma. Int J Radat Oncol Biol Phys 1999;44:563-568 DOI ScienceOn |
24 | Hoppe R. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer 1985;55:2176-2178 DOI PUBMED ScienceOn |
25 | Han Liem I, VaIdes OImos RA, BaIm AJM, et aI. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Eur J Nucl Med 1996;23:1485-1490 DOI ScienceOn |